Sellas Life Sciences Group Inc
(SLS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 39,362 | 52,627 | 47,987 | 51,496 | 21,021 |
| Marketable Securities | N/A | N/A | N/A | 2,837 | 5,786 |
| Receivables | 2,152 | 1,466 | 3,683 | 1,543 | N/A |
| Inventories | 433 | 358 | 386 | 425 | 352 |
| TOTAL | $43,684 | $55,779 | $53,455 | $56,786 | $27,548 |
| Non-Current Assets | |||||
| PPE Net | 623 | 653 | 665 | 545 | 467 |
| Intangibles | 22,997 | 22,890 | 20,877 | 20,930 | 20,981 |
| Other Non-Current Assets | 12,972 | 12,968 | 12,979 | 12,993 | 13,006 |
| TOTAL | $36,592 | $36,511 | $34,521 | $34,468 | $34,454 |
| Total Assets | $80,276 | $92,290 | $87,976 | $91,254 | $62,002 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,076 | 3,102 | 2,149 | 1,215 | 301 |
| Accounts payable and accrued liabilities | 2,036 | 1,574 | 2,660 | 1,890 | 2,092 |
| Accrued Expenses | 11,789 | 9,793 | 8,699 | 8,889 | 8,444 |
| Other current liabilities | 15,506 | 12,365 | 48,965 | 24,514 | 14,909 |
| TOTAL | $33,413 | $26,840 | $62,473 | $36,514 | $25,752 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,003 | 6,883 | 7,743 | 8,583 | 9,369 |
| Other Non-Current Liabilities | 7,477 | 6,987 | 6,821 | 6,454 | 6,529 |
| TOTAL | $18,552 | $18,946 | $19,617 | $20,120 | $20,985 |
| Total Liabilities | $51,965 | $45,786 | $82,090 | $56,634 | $46,771 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4 | 4 | 4 | 4 | 3 |
| Common Shares | 11 | 11 | 10 | 10 | 8 |
| Retained earnings | -201,352 | -181,411 | -178,875 | -130,374 | -121,087 |
| Other shareholders' equity | 151 | 151 | 151 | 1,873 | 3,664 |
| TOTAL | $28,311 | $46,504 | $5,886 | $34,620 | $15,231 |
| Total Liabilities And Equity | $80,276 | $92,290 | $87,976 | $91,254 | $62,002 |